Tokyo, Sept. 3 -- Sysmex Corporation, the world leader in haematology and blood cell count testing, has reaffirmed its commitment to India's medical treatment system, declaring the country a key pillar in its global growth strategy.

Founded in 1968, Sysmex traces its origins to an audio equipment company that successfully transformed its expertise in electrical technology into the development of blood cell detection machines.

To ensure smooth operations, the company also developed testing reagents. Initially expanding through overseas agencies, Sysmex later adopted a direct sales model to consolidate its global presence.

Under the leadership of Hisashi Ietsugu, who became president in 1996, Sysmex accelerated its global expansion with ...